Oxidative stress-related clastogenic factors in plasma from Chernobyl liquidators: Protective effects of antioxidant plant phenols, vitamins and oligoelements

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 377, Issue 2, 1997, Pages 239-246

  Emerit, I ^a   Oganesian, N ^b   Arutyunian, R ^c   Pogossian, A ^b   Sarkisian, T ^c   Cernjavski, L ^a   Levy, A ^a   Feingold, J ^d  

^a CNRS   (France)

^b Armenian Ministry of Health   (Armenia)

^c YEREVAN STATE UNIVERSITY   (Armenia)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CLASTOGEN; METAL; PHENOL DERIVATIVE; PLANT EXTRACT; VITAMIN;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD ANALYSIS; CEREBROVASCULAR ACCIDENT; CHERNOBYL ACCIDENT; CHROMOSOME ABERRATION; CHRONIC BRONCHITIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MIXTURE; ENTEROCOLITIS; HEALTH STATUS; HUMAN; HUMAN TISSUE; NEURASTHENIA; OSTEOARTHRITIS; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION SICKNESS; ULTRAFILTRATION;

EID: 0030815950     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00080-8     Document Type: Article

References (35)

1. WHO (1994) International Programme of the Health Effects of the Chernobyl Accident. Report 94/92. World Health Organization, Geneva.
2. K.O. Goh, H. Sumner, Breaks in normal human chromosomes: are they induced by a transferable substance in the plasma of irradiated persons exposed to total-body irradiation?, Radiation Res. 6 (1968) 51-60.
3. J.G. Hollowell Jr., G. Littlefield, Chromosome damage induced by plasma from irradiated patients. An indirect effect of X-ray, Proc. Soc. Exp. Biol. Med. 129 (1968) 240-241.
4. G.S. Pant, N. Kamada, Chromosome aberrations in normal leukocytes induced by the plasma of exposed individuals, Hiroshima J. Med. Sci. 26 (1977) 240-244.
5. I. Emerit, A. Levy, L. Cernjavski, R. Arutyunyan, N. Oganesian, A. Pogosian, H. Mejlumian, T. Sarkisian, M. Gulkandanian, M. Quastel, J. Goldsmith, E. Riklis, R. Kordysh, S. Poliak, L. Merklin, Transferable clastogenic activity in plasma from persons exposed as salvage personnel of the Chernobyl reactor, J. Cancer Res. Clin. Oncol. 120 (1994) 558-561.
6. I. Emerit, M. Quastel, J. Goldsmith, L. Merklin, A. Levy, L. Cernjavski, A. Alaoui-Youssefi, A. Pogosian, E. Riklis, Clastogenic factors in the plasma of children exposed at Chernobyl, Mutation Res. 373 (1997) 47-54.
7. I. Emerit, Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis, Free Radical Biol. Med. 16 (1994) 99-109.
8. I. Emerit, P. Cerutti, Tumor promoter phorbol-myristate-acetate induces a clastogenic factor in human lymphocytes, Proc. Natl. Acad. Sci. USA 79 (1982) 7509-7913.
9. I. Emerit, S.H. Khan, P. Cerutti, Treatment of lymphocyte cultures with a hypoxanthine-xanthine oxidase system induces the formation of transferable clastogenic material, Free Radical Biol. Med. 1 (1985) 51-57.
10. I. Emerit, A. Levy, G. Pagano, L. Pinto, R. Calzone, A. Zatterala, Transferable clastogenic activity in plasma from patients with Fanconi Anemia, Hum. Genet. 96 (1995) 14-20.
11. C. Auclair, A. Gouette, A. Levy, I. Emerit, Clastogenic inosine nucleotides as components of the chromosome breakage factor in scleroderma patients, Arch. Biochem. Biophys. 278 (1990) 238-244.
12. A. Alaoui-Youssefi, R. Arutyunyan, I. Emerit, Chromosome damage in PUVA-treated human lymphocytes is related to active oxygen species and clastogenic factors, Mutation Res. 309 (1994) 185-191.
13. D. Scott, The effect of irradiated plasma on normal human chromosomes and its relevance to the long-lived lymphocyte hypothesis, Cell Tissue Kinet. 2 (1969) 295-305.
14. I. Emerit, F. Garban, J. Vassy, A. Levy, P. Filipe, J. Freitas, Superoxide-mediated clastogenesis and anticlastogenic effects of exogenous superoxide dismutase, Proc. Natl. Acad. Sci. USA 93 (1996) 12799-12804.
15. I. Emerit, N. Oganesian, T. Sarkisian, R. Arutyunyan, A. Pogossian, K. Asrian, A. Levy, L. Cernjavski, Clastogenic factors in the plasma of Chernobyl accident recovery workers: anticlastogenic effect of Gingko biloba extract, Radiation Res. 144 (1995) 198-205.
16. Y. Minamiyama, T. Yoshikawa, T. Tanigawa, S. Takahashi, Y. Naito, H. Ichikawa, M. Kondo, Antioxidative effects of a processed grain food, J. Nutr. Sci. Vitaminol. 40 (1994) 467-477.
17. I. Emerit, Clastogenic factors: detection and assay, in: L. Packer, A.N. Glazer (Eds.), Methods in Enzymology, Vol. 186, Academic Press, New York, 1990, pp. 555-564.
18. S. Krivenki, S. Dryk, M. Komarovskaya, L. Karkanitsa, Ionizing radiation increases TNF/cachectin production by human peripheral blood mononuclear cells in vitro, Int. J. Hematol. 55 (1992) 127-130.
19. K.S. Iwamoto, H. McBride, Production of 13-hydroxy-octadecadienoic acid and tumor necrosis factor alpha by murine peritoneal macrophages in response to irradiation, Radiation Res. 139 (1994) 103-108.
20. I. Emerit, J.N. Fabiani, A. Levy, O. Ponzio, M. Conti, B. Brasme, P. Bienvenu, M. Hatmi, Plasma from patients exposed to ischemia reperfusion contains clastogenic factors and stimulates the chemiluminecence response of normal leukocytes, Free Radic. Biol. Med. 19 (1995) 405-415.
21. H. Hayama, K.I. Hirai, Free Radical Production of human leukocytes and effects of antiinflammatory agents: a cytochemical study, J. Kanazawa Med. Univ. 18 (1993) 277-282.
22. E. Komuro, Y. Yamamoto, E. Niki, Inhibition of lipid peroxidations by antioxidant biofactor, Vitamins 67 (1993) 455-518.
23. J. Baumann, G. Wurm, F. von Bruchhausen, Hemmung der Prostaglandinsynthese durch Flavonoide and Phenolderivate im Vergleich mit deren Superoxyd-Radicalfängereigenschaften, Arch. Pharmacol. 313 (1980) 330-341.
24. J. Robak, R.J. Gryglewski, Flavonoids are scavengers of superoxide anions, Biochem. Pharmacol. 37 (1988) 837-842.
25. W. Bors, W. Heller, C. Michel, M. Saran, Radical chemistry of flavonoid antioxidants, in: I. Emerit, L. Packer and C. Auclair (Eds.), Antioxidants in Therapy and Preventive Medicine, Plenum Press, New York, 1990, pp. 165-170.
26. R.L. Willson, Vitamin, selenium, zinc and copper interactions in free radical protection against ill-placed iron, Proc. Nutr. Soc. 46 (1987) 27-34.
27. Y. Homma, Y. Emori, T. Takenawa, Isolation and characterization of rat 3Y1 fibroblast clones overexpressing the src homology region of phospholipase C-gamma 2, J. Biol. Chem. 267 (1992) 3778-3782.
28. M.A. Pereira, L.H. Barnes, V.L. Rassman, G.V. Kellof, V.E. Steele, Use of azoxymethane-induced foci of aberrant crypts in rat clone to identify potential cancer chemopreventive agents, Carcinogenesis 15 (1994) 1049-1054.
29. M.J. Messina, V. Persky, K.D. Setchell, S. Barnes, Soy intake and cancer risk: a review of the in vitro and in vivo data, Nutr. Cancer 21 (1994) 113-131.
30. G. Peterson, S. Barnes, Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene, Biochem. Biophys. Res. Commun. 179 (1991) 661-667.
31. K. Yanagihara, A. Ito, T. Toge, M. Numoto, Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract, Cancer Res. 53 (1993) 5815-5821.
32. M. Piontek, K.J. Hengels, R. Porschen, G. Strohmeyer, Antiproliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of human gastric cancer cells, Anticancer Res. 13 (1993) 2119-2123.
33. G. Peterson, S. Barnes, Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation, Prostate 22 (1993) 335-345.
34. Y. Mousavi, H. Adlercreutz, Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture, Steroids 58 (1993) 301-304.
35. Y. Homma, J. Okabe-Kado, T. Kasukabe, M. Hozumi, K. Umezawa, Inhibition of abl oncogene tyrosine kinase induces erythroid differentiation of human myelogenous leukemia K562 cells, Jpn. J. Cancer Res. 81 (1990) 1132-1136.